Siglec-9 Polyklonaler Antikörper

Siglec-9 Polyklonal Antikörper für WB, IHC, IF-P, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, IF-P, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 13377-1-PBS

Synonyme

SIGLEC9, UNQ668/PRO1302, Siglec 9, Sialic acid-binding Ig-like lectin 9, Protein FOAP 9



Geprüfte Anwendungen

Produktinformation

13377-1-PBS bindet in WB, IHC, IF-P, ELISA Siglec-9 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen Siglec-9 fusion protein Ag4201
Vollständiger Name sialic acid binding Ig-like lectin 9
Berechnetes Molekulargewicht 463 aa, 50 kDa
Beobachtetes Molekulargewicht 55-60 kDa
GenBank-ZugangsnummerBC035365
Gene symbol Siglec-9
Gene ID (NCBI) 27180
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Sialic acid binding Ig-like lectin 9 (Siglec-9), also known as CD329, is a member of the Siglec family of glycan-recognition proteins. Siglec-9 is a type-I transmembrane protein consisting of an N-terminal extracellular region that contains an N-terminal V-set domain and two C2-set domains, a transmembrane region, and an intracellular domain with an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an ITIM-like motif (PMID: 10801862). It is expressed quite broadly among human blood leukocytes, including monocytes, neutrophils, B cells, NK cells, and minor subsets of T cells (PMID: 32322597). Siglec-9 functions as an inhibitory immune checkpoint and can be targeted to enhance therapeutic antitumor immunity (PMID: 34155121; 37460871).